(Q41563302)

3 October 2017

1 reference

title

The role of adhesion molecules in multiple sclerosis: biology, pathogenesis and therapeutic implications (English)

1 reference

3 October 2017

0 references

2

Hartung HP

1 reference

3 October 2017

Archelos JJ

1

1 reference

3 October 2017

1 July 1997

1 reference

Trends in Molecular Medicine

3 October 2017

1 reference

3 October 2017

3

1 reference

3 October 2017

7

1 reference

3 October 2017

310-321

1 reference

Multiple sclerosis: a pivotal role for the T cell in lesion development

3 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Lymphocyte homing and homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Adhesion molecules as targets for the treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Circulating adhesion molecules and inflammatory mediators in demyelination: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

1 reference

7 January 2021

Multiple sclerosis: remyelination of nascent lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Expression of ICAM-1, VCAM-1, L-selectin, and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Structure and function of adhesion receptors in leukocyte trafficking

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

The biology of PECAM-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Multiple sclerosis: immune system molecule expression in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

The adhesion molecule and cytokine profile of multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

The use of monoclonal antibodies to achieve immunological tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Immunoadhesins: principles and applications

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Investigational drug therapies of treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

An open trial of OKT3 in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Treatment of multiple sclerosis with anti-CD4 monoclonal antibody. A preliminary report on B-F5 in 21 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Immunologic responses of progressive multiple sclerosis patients treated with an anti-T-cell monoclonal antibody, anti-T12.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Phase 1 clinical trial of chimeric monoclonal anti-CD4 antibody in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Cytokines in inflammatory brain lesions: helpful and harmful

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Transcription factor NF-kappa B is activated in microglia during experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Oligosaccharide anti-infective agents

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

The selectins and their ligands

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Antisense oligonucleotides: towards clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Gene therapy in the central nervous system: direct versus indirect gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Selective localisation of neuro-specific T lymphocytes in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

Principles for adoptive T cell therapy of human viral diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901066-6

7 January 2021

10.1016/S1357-4310(97)01066-6

Identifiers

DOI

1 reference

3 October 2017

1 reference

PubMed ID

9257299